Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Sr. V.P. & Chief Info. Officer | April 03, 2006 | April 05, 2006 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 03, 2006 · Filed April 05, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ISO (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.88 · Expires 2013-04-03 | Direct | 1,391 |
Reported balance
After 2006-04-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2006-04-03 · Grant · Acquired 1,391 · Balance 1,391 F2: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. |
| NQSO (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.88 · Expires 2013-04-03 | Direct | 42,109 |
Reported balance
After 2006-04-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2006-04-03 · Grant · Acquired 42,109 · Balance 42,109 F2: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. F3: The option becomes exercisable annually as follows: 10,875 shares on April 3, 2007; 10,875 shares on April 3, 2008; 10,875 shares on April 3, 2009 and 9,484 shares on April 3, 2010. |
| Common StockSEC Table I · non-derivative | Direct | 7,992 |
Reported balance
Holding disclosure · report date 2006-04-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,992 F1: The amount of the Company's common stock beneficially owned as of the date of this transaction and held directly by the reporting person has been adjusted to reflect an acquisition of the Company's common stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)B). |
Filing footnotes · ownership attribution and instrument terms
F1: The amount of the Company's common stock beneficially owned as of the date of this transaction and held directly by the reporting person has been adjusted to reflect an acquisition of the Company's common stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)B).
F2: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan.
F3: The option becomes exercisable annually as follows: 10,875 shares on April 3, 2007; 10,875 shares on April 3, 2008; 10,875 shares on April 3, 2009 and 9,484 shares on April 3, 2010.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2006 Filed Apr 5, 2006 16:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 42,109 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0001181431-06-022391 · rrd113525.xml · derivative · entry 3 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,109 Underlying: Common Stock · 42,109 shares Expires 2013-04-03 F2 · price: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. F3 · derivative.exercise_date: The option becomes exercisable annually as follows: 10,875 shares on April 3, 2007; 10,875 shares on April 3, 2008; 10,875 shares on April 3, 2009 and 9,484 shares on April 3, 2010. Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 16:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,391 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0001181431-06-022391 · rrd113525.xml · derivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,391 Underlying: Common Stock · 1,391 shares Expires 2013-04-03 F2 · price: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 19:45 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 6,255 | $47.96 Strike: $47.96 | $299,989.80 |
DisclosureSEC source: 0001181431-05-064219 · rrd98713.xml · derivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,085 Underlying: Common Stock · 6,255 shares Expires 2009-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The unvested remainder of this option will become exercisable on May 13,2006 for 2,085 shares. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 19:45 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 6,255 | $47.96 | $299,989.80 |
DisclosureSEC source: 0001181431-05-064219 · rrd98713.xml · nonDerivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 22:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 15,000 | $38.36 Strike: $38.36 | $575,400.00 |
DisclosureSEC source: 0001181431-05-062085 · rrd97382.xml · derivative · entry 3 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,394 Underlying: Common Stock · 15,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The unvested reminder of this option is exercisable on July 1, 2006 for 18,000 shares and on July 1, 2007 for 15,394 shares. Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 22:41 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $81.93 | $1,228,950.00 |
DisclosureSEC source: 0001181431-05-062085 · rrd97382.xml · nonDerivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349 Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 22:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 15,000 | $38.36 | $575,400.00 |
DisclosureSEC source: 0001181431-05-062085 · rrd97382.xml · nonDerivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2005 Filed Jul 28, 2005 20:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 24,000 | $38.36 Strike: $38.36 | $920,640.00 |
DisclosureSEC source: 0001181431-05-042650 · rrd87279.xml · derivative · entry 3 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,394 Underlying: Common Stock · 24,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: (HD 7/1/2002) The option becomes exercise in four equal installments of 18,000 shares each beginning July 1, 2003 with a final installment of 15,394 shares on July 1, 2007. Read SEC document |
| July 27, 2005 Filed Jul 28, 2005 20:32 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 24,000 | $80.92 | $1,942,099.20 |
DisclosureSEC source: 0001181431-05-042650 · rrd87279.xml · nonDerivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349 Read SEC document |
| July 27, 2005 Filed Jul 28, 2005 20:32 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 24,000 | $38.36 | $920,640.00 |
DisclosureSEC source: 0001181431-05-042650 · rrd87279.xml · nonDerivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2005 Filed Mar 16, 2005 23:59 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017326 · rrd72669.xml · derivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2012-03-15 F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016015 · rrd36908.xml · derivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:28 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016015 · rrd36908.xml · derivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:23 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012807 · rrd11641.xml · derivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (HD-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:23 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012807 · rrd11641.xml · derivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.